Uloric Issued Black Box Warning and Can Cause Heart-Related Death
More than 8 million Americans wake up every day to a painful, throbbing arthritis called gout. Holding their child’s hand, reaching high in a cabinet for a coffee cup, washing their hair in the shower—simple things that we take for granted are incredibly difficult and excruciating for gout patients.
Takeda Introduces Uloric
Takeda, a Japanese pharmaceutical company, promised to swoop in and save the day. They promised a miracle drug that would relieve the agonizingly uncomfortable days of gout sufferers. The drug, Uloric, promised to tame the uric acid build up that causes the painful joint inflammation.
But Takeda didn’t tell the whole story.
A whistleblower lawsuit uncovered that Takeda intentionally withheld important risk information, and that they failed to report that the drug could interact with other medications.
The Maher Law Firm is investigating cases where Uloric has caused major cardiovascular problems and even heart-related deaths. Postmarket studies are also questioning whether Uloric is even effective in treating gout. Because patients taking Uloric have been shown to have a significantly higher risk of these potential cardiovascular diseases, including heart attacks, strokes, heart surgeries, and death, the FDA mandated Uloric now have a Black Box Warning, the strictest warning label given out. The warning even goes as far as instructing doctors to prescribe Uloric’s competitor, Allopurinol, before trying Uloric and to use Uloric essentially as a last-resort only.
To read more about Uloric and the Black Box Warning, please visit our Uloric site:Maher Law Firm: Uloric
The Maher Law Firm Can Help
The Maher Law Firm has been helping victims of bad drugs and other accident victims for more than 50 years. If you have taken Uloric and have suffered a heart attack, stroke, required bypass surgery or, even had a loved one die, please call us so we can advocate for you and attempt to financially compensate the wrong that has been done.